Trial of SVTampons vs Glass Vaginal Dilators in Treatment of Vaginismus

NCT ID: NCT05529407

Last Updated: 2022-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-01

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the success rates of vaginismus therapy using a tampon or a dilator during exposure

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Tampon Group

Exercises will be performed with tampon

Dilator Group

Exercises wil be performed with dilator

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaginismus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Simple Vaginal Tampon

Dilation exercises will be performed with tampon

Group Type EXPERIMENTAL

Simple Vaginal Tampon

Intervention Type DEVICE

Use of single use vaginal tampons

Glass Vaginal Dilator

Dilation exercises will be performed with vaginal dilator

Group Type EXPERIMENTAL

Glass Vaginal Trainer

Intervention Type DEVICE

Use of glass vaginal trainers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Simple Vaginal Tampon

Use of single use vaginal tampons

Intervention Type DEVICE

Glass Vaginal Trainer

Use of glass vaginal trainers

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SVT GVT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non-pregnant/non lactating women aged between 18-50
* diagnosed with primary vaginismus of Lamont level II or higher

Exclusion Criteria

* hymenal abnormalities, congenital vaginal abnormalities, vulvodynia, secondary vaginismus following physical or psychological trauma, infection, menopausal period or pelvic pathology and with any psychiatric or physiological disease.
* Patients with husbands possessing a history of sexual dysfunction (erectile dysfunction or premature ejaculation, for example)
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bezmialem Vakif University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayşe Filiz Gökmen Karasu

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bezmialem Vakif University

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Bezmialem Vakif University

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ayse Filiz Gokmen Karasu

Role: CONTACT

+905465144142

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ayse Filiz Gokmen Karasu, M.D

Role: primary

+905465144142

Ayse Filiz Ayse Filiz

Role: backup

Caglar Cetin, MD

Role: primary

+905321673930

Ayse Filiz Gokmen Karasu

Role: backup

+905465144142

References

Explore related publications, articles, or registry entries linked to this study.

Aslan M, Yavuzkir S, Baykara S. Is "Dilator Use" More Effective Than "Finger Use" in Exposure Therapy in Vaginismus Treatment? J Sex Marital Ther. 2020;46(4):354-360. doi: 10.1080/0092623X.2020.1716907. Epub 2020 Feb 13.

Reference Type BACKGROUND
PMID: 32052704 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Bezmialem.5.22. 553

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Topical Ketotifen 0.25% for Secondary Vestibulodynia
NCT07257029 NOT_YET_RECRUITING PHASE2
Improving Menstrual and VAginal Health for All
NCT06646185 NOT_YET_RECRUITING NA